600211 西藏药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)7.76024.31128.95225.20013.110
总资产报酬率 ROA (%)4.71917.03122.52418.4399.360
投入资产回报率 ROIC (%)5.69220.25526.10021.71111.028

边际利润分析
销售毛利率 (%)92.89994.21594.21895.05294.258
营业利润率 (%)43.71535.01041.34628.68518.189
息税前利润/营业总收入 (%)42.73232.58539.36627.58118.307
净利润/营业总收入 (%)39.09030.75537.66225.85114.691

收益指标分析
经营活动净收益/利润总额(%)69.75395.40581.680119.799160.019
价值变动净收益/利润总额(%)-0.2200.879-0.337-18.937-1.541
营业外收支净额/利润总额(%)0.107-0.309-0.726-0.100-0.272

偿债能力分析
流动比率 (X)2.8842.8274.6572.8732.643
速动比率 (X)2.7682.7174.4822.7792.545
资产负债率 (%)33.85733.98416.75126.45826.072
带息债务/全部投入资本 (%)19.14115.3235.97212.56513.210
股东权益/带息债务 (%)375.161489.5141,563.149689.815647.811
股东权益/负债合计 (%)180.217178.338492.663275.561281.766
利息保障倍数 (X)-41.484-14.064-23.418-25.643108.986

营运能力分析
应收账款周转天数 (天)72.15273.72475.53663.03864.691
存货周转天数 (天)328.093329.216272.415245.342291.134